RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 56 filers reported holding RECRO PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,281,139 | -20.1% | 1,076,587 | 0.0% | 0.03% | -52.9% |
| Q4 2022 | $1,604,115 | -8.6% | 1,076,587 | 0.0% | 0.07% | -20.5% |
| Q3 2022 | $1,755,000 | +105.0% | 1,076,587 | 0.0% | 0.09% | +95.6% |
| Q2 2022 | $856,000 | -55.8% | 1,076,587 | 0.0% | 0.04% | -35.7% |
| Q1 2022 | $1,938,000 | +5.3% | 1,076,587 | 0.0% | 0.07% | -19.5% |
| Q4 2021 | $1,841,000 | -17.0% | 1,076,587 | 0.0% | 0.09% | +40.3% |
| Q3 2021 | $2,218,000 | -10.8% | 1,076,587 | 0.0% | 0.06% | -60.5% |
| Q2 2021 | $2,487,000 | -17.2% | 1,076,587 | 0.0% | 0.16% | -10.3% |
| Q1 2021 | $3,004,000 | -2.1% | 1,076,587 | 0.0% | 0.18% | -22.2% |
| Q4 2020 | $3,068,000 | +35.7% | 1,076,587 | 0.0% | 0.22% | +6.6% |
| Q3 2020 | $2,261,000 | -53.8% | 1,076,587 | 0.0% | 0.21% | -62.6% |
| Q2 2020 | $4,898,000 | – | 1,076,587 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |